Gene: VCAN
Official Full Name: versicanprovided by HGNC
Gene Summary: This gene is a member of the aggrecan/versican proteoglycan family. The protein encoded is a large chondroitin sulfate proteoglycan and is a major component of the extracellular matrix. This protein is involved in cell adhesion, proliferation, proliferation, migration and angiogenesis and plays a central role in tissue morphogenesis and maintenance. Mutations in this gene are the cause of Wagner syndrome type 1. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Aug 2009]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO38391 | VCAN Knockout cell line (HCT 116) | Human | VCAN | 1:2~1:4 | Negative | Online Inquiry |
KO38392 | VCAN Knockout cell line (HEK293) | Human | VCAN | 1:3~1:6 | Negative | Online Inquiry |
KO38393 | VCAN Knockout cell line (A549) | Human | VCAN | 1:3~1:4 | Negative | Online Inquiry |
VCAN Gene Knockout Cell Lines are specialized cell models where the versican (VCAN) gene has been deliberately disrupted to facilitate the study of its biological functions and implications in disease processes. Versican, a large extracellular matrix proteoglycan, plays a crucial role in cell adhesion, proliferation, and migration, making it significant for understanding developmental biology and various pathological conditions such as cancer and heart disease.
These knockout cell lines operate by utilizing CRISPR-Cas9 technology, which allows precise editing of the VCAN gene, leading to complete loss of function. This innovative approach enables researchers to investigate the resultant phenotypic changes, cellular signaling pathways, and interactions involving the extracellular matrix. As VCAN has been linked to inflammation and tissue remodeling, these knockouts are invaluable for studying mechanisms underlying diseases characterized by aberrant extracellular matrix deposition.
The scientific importance of VCAN Gene Knockout Cell Lines extends into both basic and applied research, particularly in the fields of oncology, cardiovascular research, and regenerative medicine. This tool assists in providing insights into tumor microenvironments or fibrotic responses in cardiac tissue, thereby enhancing our understanding of how VCAN modulation could serve as a therapeutic target.
Compared to traditional knockdown methods such as RNA interference, these knockout cell lines offer persistent gene disruption, leading to more robust and reproducible data. Researchers benefit from the stability of these models, as they are less likely to experience off-target effects or transient gene silencing, creating a reliable platform for in-depth analysis.
For researchers and clinicians focused on gene function studies, disease modeling, and therapeutic discovery, VCAN Gene Knockout Cell Lines represent an essential resource. The cell lines are not only a step forward in genetic research but also promote the development of novel strategies for disease intervention.
As a leader in providing innovative biological products, our company ensures that each knockout cell line undergoes rigorous validation and quality control, empowering scientists with reliable tools essential for pioneering research.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.